Objective: To assess the effects of zinc supplementation on vitamin status in middle-aged and older volunteers. Subjects/Methods: Three hundred and eighty-seven healthy middle-aged (55-70 years) and older (70-85 years) men and women, randomly allocated to three groups to receive 15 or 30 mg Zn/day or placebo for 6 months. Dietary intake was assessed by means of a validated 4-day recall record. Fasting blood samples were simultaneously analysed for levels of plasma retinol and a-tocopherol by high-performance liquid chromatography. Erythrocyte folates were measured by a competitive immunoassay with direct chemiluminescence detection on an automatized immunoanalyser. Biochemical measurements were performed at baseline and after 3 and 6 months of zinc supplementation. Results: Plasma vitamin A levels were significantly increased proportionally with zinc dose and period of treatment, particularly at 6 months (for 15 mg Zn/day, Po0.05; for 30 mg Zn/day, Po0.0001); no significant changes were observed in the placebo group. There was no effect of zinc supplementation on vitamin E/cholesterol ratio and erythrocyte folates. Conclusions: Our results show that a long-term zinc supplementation increases plasma vitamin A levels in middle-aged and older people of similar characteristics to those involved in this study. Moreover, supplementation influences serum zinc levels but does not affect erythrocyte zinc concentration and both plasma vitamin E and erythrocyte folate status.
Introduction
Zinc is an essential component of a large number of enzymes participating in the synthesis and degradation of carbohydrates, lipids, proteins and nucleic acids as well as in the metabolism of other micronutrients. The balance among micronutrients within the body appears to be finely regulated and it is therefore very important, particularly in elderly, in whom deficiency of one or several micronutrients may have functional consequences on health. Epidemiological studies demonstrate that elderly sectors of population have higher rates of nutritional deficiency, in particular marginal zinc deficiency and/or low levels of vitamins (Gardner et al., 1997; Tebi et al., 2000; Akner and Floistrup, 2003; Chernoff, 2005) . This deficiency may contribute to various chronic and degenerative diseases associated with ageing, like immune function impairment (Chandra, 1990) , cardiovascular disease (Salonen et al., 1982) or cancer (Strain, 1994; Ho, 2004) . Micronutrient deficiencies in the elderly arise from insufficient intake and/or failure of the mechanisms of absorption and conversion into active metabolic forms. Micronutrients are clearly implicated in the ageing process and, in turn, ageing affects their bioavailability. In addition, several micronutrients seem to be involved in the decline in cognitive functions of the elderly (Ortega et al., 1997) and mental deterioration can modify nutritional status through low appetite, abnormal behaviour, and so on.
There is much evidence of interaction between zinc and a range of vitamins, particularly vitamin A, vitamin E and folic acid. Zinc is necessary for the synthesis of retinol-binding protein (RBP), which is required for mobilization of hepatic reserves and for the transport of vitamin A in the plasma. Consequently, marginal zinc intake is associated with decreased mobilization of retinol from the liver and also with a lowered concentration of transport proteins in the blood (Smith et al., 1974; Smith, 1980; Solomons and Russell, 1980; Boron et al., 1988; Mobarhan et al., 1992; Christian and West, 1998 ). The literature also shows that dietary zinc deficiency may increase the nutritional requirement for vitamin E, probably due to effects upon absorption or transport of tocopherol by the intestinal mucosa and the blood transport system or a combination of the above (Bunk et al., 1989) . Moreover, marginal or low zinc status decreases absorption of food folates because this process requires their hydrolysis by the intestinal mucosal conjugase, a zinccontaining enzyme (Milne et al., 1984) .
Few studies on the effect of zinc supplementation on these vitamins in elderly people have been undertaken. The overall objective of this paper was to investigate the effect of zinc supplementation on vitamin status in the middle-aged and older European volunteers of the ZENITH study. In particular, we compared the effects of a placebo with those of two doses of supplemental zinc (15 and 30 mg/day), which correspond approximately to 1.5 and 3 times the recommended dietary allowances of zinc for the present study population (Commission of the European Communities, 1993).
Methods

Subjects and study design
The ZENITH study design was a randomized, double-blind, placebo-controlled intervention trial in late middle-aged men and women recruited in four European centres. Participants were apparently healthy men and women aged between 55 and 70 years (Clermont-Ferrand/Theix, France (n ¼ 95) and Coleraine, Northern Ireland (n ¼ 93)) and between 70 and 85 years (Grenoble, France (n ¼ 91) and Rome, Italy (n ¼ 108)). In total, 842 volunteers (45% men and 55% women) were invited to take part in the study and were screened according to the inclusion/exclusion criteria of the ZENITH study, as reported in Table 1 . The distribution of participants by centre and sex and the baseline results of the ZENITH study are described fully elsewhere (AndriolloSanchez et al., 2005; Coudray et al., 2005; Meunier et al., 2005; Polito et al., 2005a, b) . Briefly, the preliminary results showed moderate differences in nutritional status, dietary habits and lifestyle between the two age groups and among the four European centres. A total of 433 participants were admitted to the supplementation phase of the study. During the supplementation, 43 participants dropped out from the study: 13 participants aged 55-70 years and 30 participants aged 70-85 years. In addition, three volunteers in the Italian centre were excluded because the compliance was less than 80%. At the end of the intervention phase, a total of 387 participants (196 men and 191 women) have completed the supplementation trial. Subjects were randomly assigned to one of three groups to receive either a placebo (2 capsules) or 15 mg Zn/day (2 capsules of 7.5 mg zinc) or 30 mg Zn/day (2 capsules of 15 mg zinc) for 6 months, by using function ALEA under Excel. The randomization process was standardized for the four centres. The supplemental zinc was given as zinc gluconate, which was prepared and supplied by E-Pharma (Creapharm, Gannat, France). The placebo capsules contained 199 mg lactose and 1 mg magnesium stearate and were identical in appearance to the zinc supplement. The 7.5 mg zinc capsules contained 56.9 mg zinc gluconate, 142.1 mg lactose and 1 mg magnesium stearate, whereas the 15 mg zinc capsules contained 113.7 mg zinc gluconate, 85.3 mg lactose and 1 mg magnesium stearate. Zinc capsules were distributed to the subjects at the beginning and at 3 months of the supplementation phase and were consumed by subjects in the morning with breakfast. At 3 and 6 months, the subjects were asked to return any remaining capsules, and the degree of the apparent compliance was estimated from the number of delivered capsules and the number of returned capsules. Compliance did not differ among the three supplementation groups in the middle-aged and older volunteers; the mean compliance was 498% in all groups.
Ethical consideration
Ethical approval for the study was obtained by the French Ethic Committee in France, University of Ulster Ethical 
Dietary intake
Food intake data were collected at the beginning and at the end of zinc supplementation by dieticians or trained personnel using the 4-day recall-record method (2 week and 2 weekend days) described fully by Polito et al. (2005b) . Portion sizes were related on standard portion sizes using a visual book reference standard of foods (SU-VI-MAX, 1994; DietoMetro, 1999) . Food consumption data were converted into energy, macro-and micronutrients by country-specified food composition tables (Feinberg et al., 1987a (Feinberg et al., , b, 1995 Souci et al., 1989; Food Composition Tables, 2000; McCance and Widdowson, 2002) . For foods and nutrients not present in the food composition tables, these were attributed to the compositions of similar foods derived from other databanks. Dietary adequacy was calculated comparing the nutrients with the European recommended dietary allowance (Commission of the European Communities, 1993).
Blood processing
Blood was collected at the beginning, after 3 months and at the end of zinc supplementation by venipuncture into vacutainers containing either ethylene diamine tetraacetic acid (EDTA) or heparin from overnight fasting. For zinc determination, blood was collected using trace element-free vacutainers tubes. Blood was protected from exposure to light. An aliquot of whole blood EDTA (0.5 ml) was stored at À701C immediately until required for analysis of the erythrocyte (red blood cell (RBC)) folates. Plasma was immediately separated by centrifugation and aliquots (0.5 ml) were stored at À701C until required for analysis of retinol and a-tocopherol.
Biochemical methods
For all ZENITH partners, serum and erythrocyte zinc analyses were performed at INRA-Theix (France), retinol and atocopherol analyses at INRAN-Rome (Italy) and RBC folates analyses were performed at UJF-Grenoble (France).
Serum and erythrocyte zinc levels were determined by flame atomic absorption spectrometry using previously described methods (Arnaud et al., 1985 (Arnaud et al., , 1986 . Seronorm trace element serum was used as internal quality control (Sero, Billingstad, Norway).
The determination of the plasma retinol and a-tocopherol concentrations was carried out by high-performance liquid chromatography techniques described fully by Maiani et al. (1989) . Briefly, plasma samples (200 ml) were deproteinized by the addition of ethanol, containing ascorbic acid (5g/l), retinol-acetate and a-tocopherol acetate (o1 mg/l) as an internal standard. The mixture was vortexed and then extracted twice with hexane containing butylated hydroxytoluene (0.1 g/l). The combined hexane layers were evaporated completely. The residues were reconstituted in 50 ml diethyl ether and 150 ml of mobile phase (methanol/ acetonitrile/tetrahydrofuran, 50:45:5 (by vol.) to bring the samples up to original volume; 20 ml were injected by an autosampler into a reversed-phase C 18 column and eluted isocratically at a flow rate of 1 ml/min. The peaks were detected at 325 nm for retinol and 292 nm for a-tocopherol with a multiwavelength spectrophotometer detector (PerkinElmer L.C. 95; Norwalk, CT, USA) connected to a data acquisition system (PE Nelson 1020, Perkin-Elmer).
RBC folates were measured by a competitive immunoassay with direct chemiluminescence detection on an automatized immunoanalyser (ADVIA Centaur, Bayer Health Care Diagnostics, Cergy Pontoise, France). Only paramagnetic particles were retained by a magnet and used for chemiluminescence detection. Folate concentration in the sample was inversely proportional to the light produced by the acridinium ester. Whole blood quality controls (Whole blood Lyphocheck, Biorad, ECS Division, Hercules, CA, USA) were used in each series of samples to check the reproducibility and accuracy of the determination.
The laboratory of the Human Nutrition Unit, Rome (Italy), participated in the international standards program 'Measurement quality assurance program for fat soluble vitamins in human serum' of the National Institute of Standards and Technology (NIST, Gaithersburg, MD, USA). Precision was within 17s.d. of medians for retinol and tocopherol; accuracy was þ 1.78 and þ 1.96% (mean bias %) respectively for retinol and tocopherol.
For folates, CV intrarun (repeatability) was 7.2% at 9 ng/ml, and CV interrun (reproducibility) was 11.5% (n ¼ 13, target ¼ 4.8 ng/ml) and 8.3% (n ¼ 15, target ¼ 17.2 ng/ml). The accuracy was determined by comparison to the target value of the quality control: 99.0711.4% (n ¼ 13, target ¼ 4.8 ng/ml) and 99.178.2% (n ¼ 15, target ¼ 17.2 ng/ml).
Samples from each volunteer have been analysed in the same day, to avoid analytical variations between days.
The normal threshold values considered are retinol X0.70 mmol/l (Sauberlich et al., 1974; Maiani et al., 1993) ; a-tocopherol/cholesterol X2.5 (Euronut SENECA Investigators, 1991); RBC folates X150 ng/ml for intra-erythrocyte folates (Essama-Tjani et al., 2000) .
Statistical analysis
Data are expressed as means7s.d. All data were checked for normal distribution using Shapiro-Wilk's test. The variables were considered as Gaussian, either directly, or following the transformation to natural logarithms, before statistical analysis. Logarithms were required on the following indices: zinc intake, retinol equivalent intake, folate intake and erythrocyte folates levels. Differences in baseline characterZinc supplementation and vitamin status F Intorre et al istics among the supplementation groups were tested by the two-way analysis of variance (ANOVA) followed by Tukey's HSD multiple rank test. The effect of zinc supplementation was analysed by analysis of covariance (ANCOVA) after adjusting for baseline values (Vickers and Altman, 2001) . Statistical analysis about the effect of zinc supplementation was performed on the total sample and by age (55-70 and 70-85 years), since there was no sex or country effect. Relationships between variables were determined by regression analysis. The limit of statistical significance was set at Po0.05.
Results
A description of the macro-and micronutrients intake before and after zinc supplementation by age classes and supplementation groups is shown in Tables 2 and 3 .
Comparison between age classes at baseline shows that older volunteers had significantly lower intakes of some macro-and micronutrients (energy, Po0.05; protein, Po0.001; total fats, Po0.05; carbohydrates, Po0.05; retinol equivalent, P ¼ 0.000) than middle-aged subjects. This effect was also present after 6 months of zinc supplementation for the same parameters (except for carbohydrates) and folates (Po0.05). Moreover, dietary intake remained unchanged after 6 months of supplementation period for the three supplementation groups.
Serum zinc concentration increased significantly over the 6 months of supplementation in the groups receiving 15 and 30 mg/day of zinc (from 12.471.4 to 15.072.2 mmol/l and from 13.171.4 to 17.273.5 mmol/l, respectively), with no change in the placebo group. Nevertheless, erythrocyte zinc concentration was not different between supplemented and un-supplemented subjects. At baseline, the percentage of subjects presenting a serum zinc concentration below 10.7 mmol/l, which is usually considered as the cutoff value of zinc deficiency, is 4.8% in middle-aged and 5.6% in older volunteers (Andriollo-Sanchez et al., 2005) . When the relationship between vitamin intake and status was examined at baseline and after supplementation, no correlation was observed (data not shown). Moreover, at baseline an Differences at baseline and at 6 months were tested by two-way ANOVA; no differences were observed between baseline and after 6 months of supplementation. b Differences from baseline (mean values and their 95% confidence intervals).
Zinc supplementation and vitamin status F Intorre et al interaction between zinc and these vitamins was observed: we found a moderate positive correlation between plasma vitamin A and serum zinc (r ¼ 0.12; Po0.05), between plasma vitamin A and RBC zinc (r ¼ 0.12; Po0.05) and between RBC folates and RBC zinc (r ¼ 0.10; Po0.05); a negative correlation between vitamin E/cholesterol ratio and serum zinc was observed (r ¼ À0.14; Po0.01) (data not shown). The effect of zinc supplementation on vitamin status in middle-aged and older volunteers and in the total sample, is reported respectively in Tables 4 and 5 . The results of the biochemical markers indicate that the mean values for all indices are above their respective cutoff points for normality and none of the volunteers has deficiencies in lipo-soluble vitamins and folates. For vitamin A (Table 4) , both age (Po0.05) and dose (Po0.05) effects are observed after 6 months of supplementation. For vitamin E, vitamin E/cholesterol ratio and for erythrocyte folates, only differences between age classes are observed.
Statistical analysis on the total sample (Table 5) shows that vitamin A plasma levels were significantly increased proportionally with zinc dose (for 15 mg Zn/day, Po0.05; for 30 mg Zn/day, Po0.0001) and period of treatment (plasma vitamin A levels were significantly higher after 6 months than after 3 months of supplementation). No significant changes were observed in the placebo group. Even if an age effect was observed after 6 months of supplementation, in this table the statistical analysis has been performed considering the variable 'age' as a co-variable, thus without taking it into account. There was no effect of zinc supplementation on vitamin E/cholesterol ratio. Serum lipid profile (serum triglycerides, serum total cholesterol, serum high-density lipoprotein-and low-density lipoprotein-cholesterol) remained unchanged after zinc supplementation (data not shown). For erythrocyte folate levels there was a time (Po0.001) and a dose (Po0.05) effect but no interaction time Â dose: in fact, there was an increase at 3 months and subsequently a decrease at 6 months, particularly in older volunteers.
Discussion
The purpose of this paper was to provide information about the effect of zinc supplementation on vitamin status of middle-aged and older volunteers. The tested Zn doses are considered as nutritional and supra-nutritional and thus our results should be discussed on the basis of the nutritional/ physiological effect, but not of the pharmacological one. The mean daily zinc intake is about 10 mg/day (10.573.5 mg/day at the beginning and 10.473.2 mg/day at the end of the supplementation phase) and the UL (tolerable upper intake Differences at baseline and at 6 months were tested by two-way ANOVA; no differences were observed between baseline and after 6 months of supplementation. b Differences from baseline (mean values and their 95% confidence intervals).
Zinc supplementation and vitamin status F Intorre et al level) for adults were set at 40 mg/day, including dietary and supplemental zinc (Food and Nutrition Board, 2001 ). Many studies have been undertaken to investigate the effects of zinc supplementation on various diseases or physiological conditions in elderly people or in subjects having dietary or biochemical zinc deficiency (Stefanidou et al., 2006) . Most of these studies have been performed among hospitalized or institutionalized elderly or focussed mainly on the relationship between zinc status and immune function (Pepersack et al., 2001; Mitchell et al., 2003; Chandra, 2004) , while data in elderly free living people are scarce. Results are heterogeneous and conflicting but in agreement with the importance of zinc supplementation in case of deficiency or in case of altered metabolism associated with reduced immune response (Turnlund et al., 1986; Cousin, 1989; McClain and Stuart, 1990; Bales et al., 1994; Sturniolo et al., 1994; Fortes et al., 1998; Brown et al., 2001; Pepersack et al., 2001; Mitchell et al., 2003; Chandra, 2004) .
In our study, we have enrolled free-living elderly volunteers considered as healthy after the clinical examination and the medical interview and the percentage of subjects presenting a serum zinc concentration below 10.7 mmol/l (cutoff value of zinc deficiency) was 4.8% for middle-aged and 5.6% for older. This prevalence of zinc deficiency was not detected in other studies carried out on hospitalized elderly, in which about one-third of subjects had plasma zinc below the cutoff value of deficiency (Schmuck et al., 1996; Pepersack et al., 2001) .
At the start of the supplementation phase, our results show differences in macro-and micronutrients intake and vitamin status between middle-aged and older volunteers. Evidence of inadequate dietary intakes of vitamin A, vitamin E and folates is lacking and the biochemical indicators suggest that the circulating levels of vitamins are in the cutoff point of normality. These findings are in disagreement with some literature data on similarly aged Europeans who have inadequate vitamin A and folate intake and limiting vitamin nutritional status (Euronut SENECA investigators, 1991; Maiani et al., 1992; Hallfrish et al., 1994; Haveman-Nies et al., 2001; Pirlich and Lochs, 2001; Ferry et al., 2005; Tur et al., 2005) . In our study, no vitamin deficiencies are observed in all age groups, probably because of the specific selection criteria used for the enrollment of apparently healthy free-living volunteers (Table 1) . Differences at baseline, at 3 months and at 6 months were tested by two-way ANOVA. b Differences from baseline (mean values and their 95% confidence intervals).
Concerning supplementation, our results show that vitamin A plasma levels increased significantly over the 6 months of zinc supplementation in both groups that received 15 or 30 mg Zn/day. It is well known that zinc is necessary for the synthesis of RBP, which is a serum carrier for transport to target tissues, having a short half life of 12 h (Smith et al., 1974; Smith, 1980; Solomons and Russell, 1980; Boron et al., 1988; Mobarhan et al., 1992; Rahman et al., 2002) . Several studies have confirmed the positive correlation between vitamin A plasma levels and plasma RBP (Solomons et al., 1990; Hix et al., 2004) and between serum zinc and RBP (Udomkesmalee et al., 1990) . In our study, we have not evaluated the visceral protein nutritional status (RBP, prealbumin, transferrin) of our volunteers but we can hypothesize, on the basis of the correlations reported above, that it was good. Moreover, in the elderly, the generally good vitamin A status is probably due to large hepatic retinol stores and reduced renal clearance of retinyl esters (Krasinski et al., 1989 (Krasinski et al., , 1990 . Our hypothesis is that zinc supplementation operates on vitamin A metabolism even in adequate zinc nutritional status, improving the RBP activity and consequently the mobilization of hepatic reserves and the transport of vitamin A in the plasma.
On the contrary, no significant changes in vitamin E, serum lipid profile and vitamin E/cholesterol ratio levels were observed over the 6 months of zinc supplementation in subjects who received 15 or 30 mg Zn/day compared to unsupplemented subjects. It has been demonstrated that Zn deficiency significantly reduces the absolute concentration of plasma vitamin E as well as the plasma vitamin E/plasma total cholesterol ratio (Bunk et al., 1989) . Indeed, vitamin E metabolism is closely linked to the complex mechanism that mediates and controls lipid and lipoprotein metabolism (Kayden and Traber, 1993; Traber and Arai, 1999) . In our study, the absence of zinc effects on vitamin E is probably due to zinc supplementation on subjects with adequate vitamin E status and without zinc deficiency.
For erythrocyte folate levels, a moderate increase was observed across the three groups after 3 months of supplementation and subsequently at 6 months a decrease to baseline values, particularly for older volunteers. Literature data on the effect of zinc supplementation on erythrocyte folate levels are scarce and controversial. Some studies found low zinc intake to decrease folate absorption, while other studies found folic acid supplementation to impair zinc utilization in individuals with marginal zinc status (King and Keen, 1999; Food and Nutrition Board, 2001 ); a possible explanation is that the enzyme responsible for intestinal hydrolysis of dietary folates to their monoglutamate forms (conjugase) is probably zinc-dependent (Milne et al., 1984) . Other observations suggest an inverse relationship between folic acid intake and zinc nutriture and indicate a relationship between folic acid and zinc at intestinal level; in particular it has been demonstrated that under normal physiological conditions a mutual interaction between folates and zinc exists at the site of intestinal Zinc supplementation and vitamin status F Intorre et al transport (Ghishan et al., 1986; Kauwell et al., 1995) . Moreover, it is well known the interaction between folates and other nutrients and that the effect of physiological zinc supplementation is related to the levels of the other cations, such as iron (Prasad, 1993) ; folic acid works closely together with vitamin B12 to regulate the formation of RBCs and to help iron function properly in the body. Besides these physiological interactions, the trend of erythrocyte folate levels could be explained by a change in dietary folate intake during the study and the possible interaction between zinc and folates.
It is important to underline that even if we have no dietary folate data at 3 months, we can observe a trend of decrease in folate intake after 6 months of supplementation (Table 3) . Besides, considering our results, we can hypothesize that in the first period of supplementation, low zinc doses may favourably affect folate metabolism as reported by Chandler et al. (1986) ; after 6 months of supplementation when higher doses of zinc and smaller doses of folate are consumed, there is probably an inhibitory effect of zinc on the active transport absorption process and consequently on folate metabolism, confirming the findings reported by Ghishan et al. (1986) .
Zinc supplementation with 15 and 30 mg/day is safe and well tolerated and does not have adverse biological effects, as it was checked by the complete clinical examination performed at baseline and every month during the supplementation period: subjects receiving zinc supplementation of both 15 and 30 mg/day did not experience significant adverse effects such as headache, vomiting, nausea and gastric irritation, as well as the placebo group. In conclusion, even if our volunteers had optimal nutritional status, the long-term supplementation with two doses of zinc revealed little evidence of beneficial effects besides from improving plasma vitamin A levels and increasing serum zinc levels; indeed, the tested zinc doses affect neither plasma vitamin E nor erythrocyte folate status.
